LogicBio Therapeutics (LOGC) – Hot FDA News
-
LogicBio Therapeutics (LOGC) Announces FDA Lifts Clinical Hold on SUNRISE Trial in Pediatric Patients with Methylmalonic Acidemia
-
LogicBio Therapeutics (LOGC) Announces Phase 1/2 SUNRISE Trial of LB-001 Placed on Hold by FDA
-
Back to LOGC Stock Lookup